Detail Information of Post-Translational Modifications

General Information of Drug Transporter (DT)
DT ID	DTD0264 Transporter Info
Gene Name	SLC2A6
Transporter Name	Glucose transporter type 6
Gene ID	11182
UniProt ID	Q9UGQ3

Post-Translational Modification of This DT
Overview of SLC2A6 Modification Sites with Functional and Structural Information
Sequence	M Q E P L L G A E G P D Y D T F P E K P P P S P G D R A R V G T L Q N K R V F L A T F A A V L G N F S F G Y A L V Y T S P V I P A L E R S L D P D L H L T K S Q A S W F G S V F T L G A A A G G L S A M I L N D L L G R K L S I M F S A V P S A A G Y A L M A G A H G L W M L L L G R T L T G F A G G L T A A C I P V Y V S E I A P P G V R G A L G A T P Q L M A V F G S L S L Y A L G L L L P W R W L A V A G E A P V L I M I L L L S F M P N S P R F L L S R G R D E E A L R A L A W L R G T D V D V H W E F E Q I Q D N V R R Q S S R V S W A E A R A P H V C R P I T V A L L M R L L Q Q L T G I T P I L V Y L Q S I F D S T A V L L P P K D D A A I V G A V R L L S V L I A A L T M D L A G R K V L L F V S A A I M F A A N L T L G L Y I H F G P R P L S P N S T A G L E S E S W G D L A Q P L A A P A G Y L T L V P L L A T M L F I M G Y A V G W G P I T W L L M S E V L P L R A R G V A S G L C V L A S W L T A F V L T K S F L P V V S T F G L Q V P F F F F A A I C L V S L V F T G C C V P E T K G R S L E Q I E S F F R T G R R S F L R
PTM type	X-N-glycosylation X-Phosphorylation X: Amino Acid

N-glycosylation
Asparagine	1 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A6			[1]
Role of PTM	Potential impacts
Modified Residue	Asparagine	Modified Location	370
Experimental Method	Co-Immunoprecipitation
Detailed Description	N-linked Glycosylation at SLC2A6 Asparagine 370 has the potential to affect its expression or activity.
Phosphorylation
Serine	5 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A6			[2] , [3]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	23
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Serine 23 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	51
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Serine 51 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	60
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Serine 60 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC2A6			[5]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	490
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Serine 490 has the potential to affect its expression or activity.
PTM Phenomenon 5	Have the potential to influence SLC2A6			[3] , [6]
Role of PTM	Potential impacts
Modified Residue	Serine	Modified Location	496
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Serine 496 has the potential to affect its expression or activity.
Threonine	3 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A6			[3]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	15
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Threonine 15 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	42
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Threonine 42 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Threonine	Modified Location	59
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Threonine 59 has the potential to affect its expression or activity.
Tyrosine	4 PTM Phenomena Related to This Residue		Click to Show/Hide the Full List
PTM Phenomenon 1	Have the potential to influence SLC2A6			[7]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	13
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Tyrosine 13 has the potential to affect its expression or activity.
PTM Phenomenon 2	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	54
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Tyrosine 54 has the potential to affect its expression or activity.
PTM Phenomenon 3	Have the potential to influence SLC2A6			[4]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	58
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Tyrosine 58 has the potential to affect its expression or activity.
PTM Phenomenon 4	Have the potential to influence SLC2A6			[8]
Role of PTM	Potential impacts
Modified Residue	Tyrosine	Modified Location	297
Experimental Method	Co-Immunoprecipitation
Detailed Description	Phosphorylation at SLC2A6 Tyrosine 297 has the potential to affect its expression or activity.

References
1	dbPTM in 2022: an updated database for exploring regulatory networks and functional associations of protein post-translational modifications. Nucleic Acids Res. 2022 Jan 7;50(D1):D471-D479. (ID: GTR6_HUMAN)
2	UniProt: a worldwide hub of protein knowledge. Nucleic Acids Res. 2019 Jan 8;47(D1):D506-D515.
3	A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
4	In situ sample processing approach (iSPA) for comprehensive quantitative phosphoproteome analysis. J Proteome Res. 2014 Sep 5;13(9):3896-904.
5	Proteogenomics connects somatic mutations to signalling in breast cancer. Nature. 2016 Jun 2;534(7605):55-62.
6	Combined inhibition of receptor tyrosine and p21-activated kinases as a therapeutic strategy in childhood ALL. Blood Adv. 2018 Oct 9;2(19):2554-2567.
7	Ultra-deep tyrosine phosphoproteomics enabled by a phosphotyrosine superbinder. Nat Chem Biol. 2016 Nov;12(11):959-966.
8	Quantitative phosphoproteomic analysis of T cell receptor signaling reveals system-wide modulation of protein-protein interactions. Sci Signal. 2009 Aug 18;2(84):ra46.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.

Detail Information of Post-Translational Modifications

Visitor Map

Correspondence